Morgan Stanley
MS
$215.50
-1.31%
Morgan Stanley is a global financial services firm offering investment banking, institutional trading, and wealth and asset management services across 42 countries. It is a market leader in wealth management with $9.3 trillion in client assets and a top-10 U.S. banking franchise by deposits, distinguishing itself through a balanced mix of advisory, trading, and fee-based revenue. The current investor narrative centers on the firm's ability to sustain double-digit revenue growth driven by a rebound in investment banking fees and continued expansion in wealth management, while navigating a rising rate environment and potential regulatory shifts. Recent quarterly results showed 22.4% YoY revenue growth, reinforcing optimism around earnings momentum and capital return programs.…
MS
Morgan Stanley
$215.50
Related headlines
MS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $224.33 and implied upside of +4.1% versus the current price.
Average Target
$224.33
0 analysts
Implied Upside
+4.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$184 - $262
Analyst target range
Morgan Stanley is covered by 21 analysts, with a consensus recommendation of 'Buy' (mean rating 2.4 on a 1-5 scale, where 1 is Strong Buy). The average price target is $224.33, implying a 1.8% downside from the current price of $228.55. The distribution shows a bullish lean, with recent actions from UBS and BofA reiterating Buy ratings, while Goldman Sachs and Citigroup maintain Neutral. The target range spans from a low of $184.00 to a high of $262.00. The high target of $262 implies 14.6% upside and likely assumes continued revenue growth from investment banking and wealth management, along with multiple expansion. The low target of $184 implies 19.5% downside and may reflect risks from a slowdown in capital markets activity or margin compression. The spread between low and high ($78) is 34% of the average target, indicating moderate uncertainty. Recent ratings have been stable, with no major downgrades, suggesting analyst conviction is relatively high.
Drowning in data?
Find the real signal!
Bulls vs Bears: MS Investment Factors
Morgan Stanley presents a balanced risk/reward profile. The bull case is supported by accelerating revenue growth (22.4% YoY), expanding margins (operating margin up to 21.5%), and a PEG ratio of 0.60 suggesting undervaluation relative to growth. The bear case highlights the stock's proximity to its 52-week high (98.4% of range), negative free cash flow, and elevated debt levels. The single most important tension is whether the rebound in investment banking fees is sustainable; if capital markets activity continues to improve, the stock could re-rate higher, but a slowdown could lead to multiple compression. Currently, the evidence slightly favors the bull case given the strong earnings momentum and attractive valuation on a growth-adjusted basis.
Bullish
- Accelerating Revenue Growth: Q2 2026 revenue grew 22.4% YoY to $34.47B, accelerating from 6.5% YoY growth in the prior year quarter. This marks the third consecutive quarter of double-digit growth, driven by a rebound in investment banking fees and wealth management expansion.
- Strong Profitability and Margins: Net income rose 57.7% YoY to $5.58B, with net margin expanding to 16.2% from 12.6% a year ago. Operating margin improved to 21.5% from 16.4%, reflecting strong operating leverage and higher-margin wealth management fees.
- Undervalued on PEG Ratio: The PEG ratio of 0.60 suggests the stock is undervalued relative to its earnings growth rate. With a forward P/E of 17.4x and estimated EPS growth of ~15%, the stock offers a compelling growth-at-a-reasonable-price (GARP) profile.
- Robust Wealth Management Franchise: Wealth Management generated $8.43B in Q2 2026 revenue, supported by $9.3 trillion in client assets. This fee-based revenue stream provides stability and growth, reducing earnings volatility from capital markets.
Bearish
- High Debt-to-Equity Ratio: The debt-to-equity ratio of 4.26 is elevated, typical for a bank holding company but still a risk in rising rate environments. Interest expense of $13.12B in Q2 2026 consumed a significant portion of operating income.
- Negative Free Cash Flow: Trailing twelve-month free cash flow was negative $1.05B, largely due to working capital swings from trading activities. While not unusual for a financial firm, it limits flexibility for organic investments.
- Stock Near 52-Week High: At $228.55, the stock is at 98.4% of its 52-week high of $232.25, leaving limited upside from current levels. The average analyst target of $224.33 implies a 1.8% downside, suggesting the stock may be fully priced.
- Analyst Downgrade Risk: Recent news highlights a wave of downgrades for bank stocks as valuations peak. With the stock up 61.4% over the past year, any earnings miss could trigger profit-taking and multiple compression.
MS Technical Analysis
Morgan Stanley is in a sustained uptrend, with the stock up 61.4% over the past year, significantly outperforming the S&P 500's 20.9% gain. The current price of $228.55 sits at 98.4% of its 52-week range ($135.26–$232.25), indicating the stock is near its highs and reflecting strong bullish momentum. This positioning suggests the market is pricing in continued positive catalysts, though it also raises the risk of short-term overextension. Short-term momentum is accelerating, with the stock gaining 4.8% over the past month and 22.0% over the past three months, outpacing the S&P 500's 0.6% and 6.3% returns, respectively. The 1-month relative strength of 4.2 confirms strong near-term buying pressure, and the 3-month trend aligns with the longer-term uptrend, showing no divergence. The stock's beta of 1.22 indicates moderately higher volatility than the market, which is typical for a financial stock. Key support lies near the 52-week low of $135.26, while resistance is at the 52-week high of $232.25. A breakout above $232.25 would signal a continuation of the uptrend, while a breakdown below recent support near $200 could indicate a trend reversal. The 1.22 beta implies that for every 1% move in the S&P 500, MS tends to move 1.22%, making it a relatively volatile holding.
Beta
1.22
1.22x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$136-$232
Price range past year
Annual Return
+52.9%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | -4.2% | +0.3% |
| 3m | +14.1% | +4.7% |
| 6m | +14.0% | +7.5% |
| 1y | +52.9% | +18.4% |
| ytd | +18.5% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Revenue growth has been robust and accelerating, with Q2 2026 revenue of $34.47 billion up 22.4% year-over-year, compared to 6.5% YoY growth in the prior year quarter. The trailing twelve-month revenue reached $126.53 billion, driven by strong performance in Wealth Management ($8.43 billion in Q2) and Institutional Securities ($7.93 billion). The multi-quarter trend shows revenue growth accelerating from 0.5% in Q2 2025 to 22.4% in Q2 2026, reflecting a sharp rebound in investment banking and trading activity. Profitability is solid, with net income of $5.58 billion in Q2 2026, up from $3.54 billion a year ago, and a net margin of 16.2% (trailing 14.7%). Gross margin improved to 61.6% from 54.7% in the prior year quarter, driven by higher-margin wealth management fees. Operating margin expanded to 21.5% from 16.4%, indicating strong operating leverage. The balance sheet shows a debt-to-equity ratio of 4.26, which is high but typical for a bank holding company, and a current ratio of 1.17, suggesting adequate short-term liquidity. Free cash flow was negative $1.05 billion over the trailing twelve months, largely due to working capital swings from trading activities, but the firm generates substantial operating cash flow from its core businesses. Return on equity (ROE) of 15.1% is strong and above the industry average, reflecting efficient capital use.
Quarterly Revenue
$34.5B
2026-06
Revenue YoY Growth
+22.4%
YoY Comparison
Gross Margin
61.7%
Latest Quarter
Free Cash Flow
$-1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 17.2x, while the forward P/E is 17.4x, implying the market expects stable earnings growth. The gap between trailing and forward P/E is minimal, suggesting earnings are expected to remain near current levels. Compared to the industry average (not provided, but typically for capital markets firms around 15-18x), MS trades roughly in line with peers. The PEG ratio of 0.60 suggests the stock is undervalued relative to its earnings growth rate, as a PEG below 1.0 typically indicates undervaluation. Historically, MS's trailing P/E has ranged from about 11x to 27x over the past two years. The current 17.2x is near the middle of this range, indicating the stock is neither overvalued nor undervalued relative to its own history. The P/B ratio of 2.50 is above the historical average of around 1.5-1.6, suggesting the market is pricing in higher future returns on equity, which is consistent with the improved ROE.
PE
17.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Morgan Stanley's high debt-to-equity ratio of 4.26 is a key financial risk, as rising interest rates increase interest expense ($13.12B in Q2 2026). Negative free cash flow of -$1.05B TTM, while partly due to working capital swings, limits financial flexibility. Revenue concentration in capital markets (Institutional Securities contributed $7.93B in Q2) exposes the firm to cyclical downturns in M&A and trading activity. The net margin of 16.2%, though improved, is still below pre-pandemic highs, indicating room for further operating leverage but also vulnerability to cost pressures.
Market & Competitive Risks: The stock's beta of 1.22 implies higher market sensitivity, making it vulnerable to macro shocks. Trading at a P/B of 2.50x, above the historical average of ~1.5x, the stock is pricing in strong future returns on equity; any disappointment could lead to multiple compression. Competitive threats include fintech disruptors in wealth management and other bulge-bracket banks vying for investment banking market share. Recent analyst downgrades for bank stocks (per news) highlight valuation risk, with the stock up 61.4% over the past year, potentially pricing in perfection.
Worst-Case Scenario: A sharp downturn in capital markets (e.g., recession, geopolitical crisis) could cause investment banking fees to collapse, revenue to decline 15-20%, and earnings to fall sharply. Combined with multiple compression, the stock could drop to the analyst low target of $184, implying a 19.5% downside from $228.55. In a severe scenario, the stock could revisit the 52-week low of $135.26, representing a 40.8% loss from current levels. This worst case would likely require a prolonged bear market in financials and a significant credit event.
